KUGADO
LIVE

Serial Number

99525386

Owner

Glaxo Group Limited

Attorney

Elizabeth K. Rucki

Filing Date

Dec 2, 2025

Add to watchlist:

No watchlists yet
View on USPTO

KUGADO Trademark

Serial Number: 99525386 • Registration: 8295623

KUGADO is a trademark filed by Glaxo Group Limited on December 2, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Glaxo Group Limited (128 trademarks)

GSK Medicines Research Centre
Stevenage SG12NY , GB

Entity Type: 77

Trademark Details

Filing Date

December 2, 2025

Registration Date

June 9, 2026

Published for Opposition

April 21, 2026

Goods & Services

Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives

Filing History

REGISTERED-PRINCIPAL REGISTER
Jun 9, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 21, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 21, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 15, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 26, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 25, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 25, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 25, 2026 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 12, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 12, 2026 GNSL
SUSPENSION LETTER WRITTEN
Feb 12, 2026 CNSL
ASSIGNED TO EXAMINER
Feb 10, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 2, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 2, 2025 NWOS
NEW APPLICATION ENTERED
Dec 2, 2025 NWAP